These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26106896)

  • 1. Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine Mapping.
    Wallace C; Cutler AJ; Pontikos N; Pekalski ML; Burren OS; Cooper JD; García AR; Ferreira RC; Guo H; Walker NM; Smyth DJ; Rich SS; Onengut-Gumuscu S; Sawcer SJ; Ban M; Richardson S; Todd JA; Wicker LS
    PLoS Genet; 2015 Jun; 11(6):e1005272. PubMed ID: 26106896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).
    Alcina A; Fedetz M; Ndagire D; Fernández O; Leyva L; Guerrero M; Abad-Grau MM; Arnal C; Delgado C; Lucas M; Izquierdo G; Matesanz F
    PLoS One; 2009; 4(1):e4137. PubMed ID: 19125193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stochastic search and joint fine-mapping increases accuracy and identifies previously unreported associations in immune-mediated diseases.
    Asimit JL; Rainbow DB; Fortune MD; Grinberg NF; Wicker LS; Wallace C
    Nat Commun; 2019 Jul; 10(1):3216. PubMed ID: 31324808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.
    Lowe CE; Cooper JD; Brusko T; Walker NM; Smyth DJ; Bailey R; Bourget K; Plagnol V; Field S; Atkinson M; Clayton DG; Wicker LS; Todd JA
    Nat Genet; 2007 Sep; 39(9):1074-82. PubMed ID: 17676041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
    Vella A; Cooper JD; Lowe CE; Walker N; Nutland S; Widmer B; Jones R; Ring SM; McArdle W; Pembrey ME; Strachan DP; Dunger DB; Twells RC; Clayton DG; Todd JA
    Am J Hum Genet; 2005 May; 76(5):773-9. PubMed ID: 15776395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.
    Maier LM; Lowe CE; Cooper J; Downes K; Anderson DE; Severson C; Clark PM; Healy B; Walker N; Aubin C; Oksenberg JR; Hauser SL; Compston A; Sawcer S; ; De Jager PL; Wicker LS; Todd JA; Hafler DA
    PLoS Genet; 2009 Jan; 5(1):e1000322. PubMed ID: 19119414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.
    Brand OJ; Lowe CE; Heward JM; Franklyn JA; Cooper JD; Todd JA; Gough SC
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):508-12. PubMed ID: 17371467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
    Fortune MD; Guo H; Burren O; Schofield E; Walker NM; Ban M; Sawcer SJ; Bowes J; Worthington J; Barton A; Eyre S; Todd JA; Wallace C
    Nat Genet; 2015 Jul; 47(7):839-46. PubMed ID: 26053495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
    Dandine-Roulland C; Perdry H
    Eur J Hum Genet; 2015 Oct; 23(10):1357-63. PubMed ID: 25585700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association mapping via evolution-based clustering of haplotypes.
    Tachmazidou I; Verzilli CJ; De Iorio M
    PLoS Genet; 2007 Jul; 3(7):e111. PubMed ID: 17616979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.
    Dendrou CA; Plagnol V; Fung E; Yang JH; Downes K; Cooper JD; Nutland S; Coleman G; Himsworth M; Hardy M; Burren O; Healy B; Walker NM; Koch K; Ouwehand WH; Bradley JR; Wareham NJ; Todd JA; Wicker LS
    Nat Genet; 2009 Sep; 41(9):1011-5. PubMed ID: 19701192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
    J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cis-acting regulatory variant in the IL2RA locus.
    Qu HQ; Verlaan DJ; Ge B; Lu Y; Lam KC; Grabs R; Harmsen E; Hudson TJ; Hakonarson H; Pastinen T; Polychronakos C
    J Immunol; 2009 Oct; 183(8):5158-62. PubMed ID: 19794070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia.
    Pitzalis M; Zavattari P; Murru R; Deidda E; Zoledziewska M; Murru D; Moi L; Motzo C; Orrù V; Costa G; Solla E; Fadda E; Schirru L; Melis MC; Lai M; Mancosu C; Tranquilli S; Cuccu S; Rolesu M; Secci MA; Corongiu D; Contu D; Lampis R; Nucaro A; Pala G; Pacifico A; Maioli M; Frongia P; Chessa M; Ricciardi R; Lostia S; Marinaro AM; Milia AF; Landis N; Zedda MA; Whalen MB; Santoni F; Marrosu MG; Devoto M; Cucca F
    BMC Med Genet; 2008 Jan; 9():3. PubMed ID: 18205952
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Buhelt S; Laigaard HM; von Essen MR; Ullum H; Oturai A; Sellebjerg F; Søndergaard HB
    Front Immunol; 2021; 12():676141. PubMed ID: 34386002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type I diabetes association of the IL2RA locus.
    Qu HQ; Bradfield JP; Bélisle A; Grant SF; Hakonarson H; Polychronakos C;
    Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S42-8. PubMed ID: 19956099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-mapping genetic associations.
    Hutchinson A; Asimit J; Wallace C
    Hum Mol Genet; 2020 Sep; 29(R1):R81-R88. PubMed ID: 32744321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine mapping of disease genes using tagging SNPs.
    Sjölander A; Hössjer O; Hartman LW; Humphreys K
    Ann Hum Genet; 2007 Nov; 71(Pt 6):815-27. PubMed ID: 17587339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flashfm approach for fine-mapping multiple quantitative traits.
    Hernández N; Soenksen J; Newcombe P; Sandhu M; Barroso I; Wallace C; Asimit JL
    Nat Commun; 2021 Oct; 12(1):6147. PubMed ID: 34686674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.